<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 11 May 2021 17:23:57 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>高端制剂爆发了！7大微球销售大涨，丽珠、绿叶“猛攻”微球制剂，齐鲁、长春金赛发力</title><link>https://mp.weixin.qq.com/s/a-BuxzaWnV9GNaZgRc9Q9Q</link><description></description><content:encoded><![CDATA[高端制剂爆发了！7大微球销售大涨，丽珠、绿叶“猛攻”微球制剂，齐鲁、长春金赛发力]]></content:encoded><pubDate>Tue, 11 May 2021 16:10:50 +0800</pubDate></item><item><title>【瞩目】齐鲁2款注射剂过评！11个品种入局第五批集采</title><link>https://mp.weixin.qq.com/s/VSZCdNRz0GDSix6Z4bdi4A</link><description></description><content:encoded><![CDATA[【瞩目】齐鲁2款注射剂过评！11个品种入局第五批集采]]></content:encoded><pubDate>Tue, 11 May 2021 16:10:50 +0800</pubDate></item><item><title>【市场】暴涨980%的抗癫痫药，国产第2家诞生</title><link>https://mp.weixin.qq.com/s/6ns-VbJ6tzSEeRIz9ib5ug</link><description></description><content:encoded><![CDATA[【市场】暴涨980%的抗癫痫药，国产第2家诞生]]></content:encoded><pubDate>Tue, 11 May 2021 16:10:50 +0800</pubDate></item><item><title>【火热招商中】千人大会！化学创新药与改良型新药CMC论坛</title><link>https://mp.weixin.qq.com/s/q0vUM1J1Kg4NejUuHGUM2A</link><description></description><content:encoded><![CDATA[【火热招商中】千人大会！化学创新药与改良型新药CMC论坛]]></content:encoded><pubDate>Tue, 11 May 2021 16:10:50 +0800</pubDate></item><item><title>零售495个过亿产品曝光！恒瑞、以岭独家产品冲上10亿，豪森1类新药暴涨1200%</title><link>https://mp.weixin.qq.com/s/1N959zlyBjV2U0TAAzV5Rw</link><description></description><content:encoded><![CDATA[零售495个过亿产品曝光！恒瑞、以岭独家产品冲上10亿，豪森1类新药暴涨1200%]]></content:encoded><pubDate>Mon, 10 May 2021 17:03:10 +0800</pubDate></item><item><title>【火爆】科伦两大重磅新品将面世，今年已拿下6个高端仿制药</title><link>https://mp.weixin.qq.com/s/M93tNduEPaxP6f2zKs09lg</link><description></description><content:encoded><![CDATA[【火爆】科伦两大重磅新品将面世，今年已拿下6个高端仿制药]]></content:encoded><pubDate>Mon, 10 May 2021 17:03:10 +0800</pubDate></item><item><title>【瞩目】华东20亿大品种将获批，恒瑞、海正已开始抢占市场</title><link>https://mp.weixin.qq.com/s/4LLU4Z4cHxj62lnFyPjcOQ</link><description></description><content:encoded><![CDATA[【瞩目】华东20亿大品种将获批，恒瑞、海正已开始抢占市场]]></content:encoded><pubDate>Mon, 10 May 2021 17:03:10 +0800</pubDate></item><item><title>【焦点】石药大卖25亿，拿下这个脂质体注射液首家过评</title><link>https://mp.weixin.qq.com/s/S42ZGs2fJw6QF9Kn9hwb7g</link><description></description><content:encoded><![CDATA[【焦点】石药大卖25亿，拿下这个脂质体注射液首家过评]]></content:encoded><pubDate>Mon, 10 May 2021 17:03:10 +0800</pubDate></item><item><title>正大天晴、齐鲁、豪森......47个新药获批临床！50亿明星药绿叶拿下，罗氏4款新药获批</title><link>https://mp.weixin.qq.com/s/44BopWPt52ckjTV8A4Lhhg</link><description></description><content:encoded><![CDATA[正大天晴、齐鲁、豪森......47个新药获批临床！50亿明星药绿叶拿下，罗氏4款新药获批]]></content:encoded><pubDate>Sun, 09 May 2021 07:44:25 +0800</pubDate></item><item><title>复宏汉霖：差异化与成本领先的兼容实践</title><link>https://mp.weixin.qq.com/s/yLPU1yVEVSU_W1X5W4eUKg</link><description></description><content:encoded><![CDATA[复宏汉霖：差异化与成本领先的兼容实践]]></content:encoded><pubDate>Sat, 08 May 2021 07:57:13 +0800</pubDate></item><item><title>367家药企晒2020成绩单！上药、九州通、白云山……45家营收超百亿，10家净利润超30亿</title><link>https://mp.weixin.qq.com/s/fdOT-E390OtkOufeHw8e4Q</link><description></description><content:encoded><![CDATA[367家药企晒2020成绩单！上药、九州通、白云山……45家营收超百亿，10家净利润超30亿]]></content:encoded><pubDate>Fri, 07 May 2021 17:01:04 +0800</pubDate></item><item><title>【瞩目】冲刺第五批集采！国内药企围攻50亿抗菌药，倍特再下一城</title><link>https://mp.weixin.qq.com/s/nvAkr60TX5SjlgRfH6HMag</link><description></description><content:encoded><![CDATA[【瞩目】冲刺第五批集采！国内药企围攻50亿抗菌药，倍特再下一城]]></content:encoded><pubDate>Fri, 07 May 2021 17:01:04 +0800</pubDate></item><item><title>【关注】对飚恒瑞、赛诺菲！四川药企“抢食”40亿抗肿瘤注射剂</title><link>https://mp.weixin.qq.com/s/XXXDyALM5DAvgErd-L94FA</link><description></description><content:encoded><![CDATA[【关注】对飚恒瑞、赛诺菲！四川药企“抢食”40亿抗肿瘤注射剂]]></content:encoded><pubDate>Fri, 07 May 2021 17:01:04 +0800</pubDate></item><item><title>【FDA】4月，4款创新药来袭！今年已有20款获批</title><link>https://mp.weixin.qq.com/s/kTutJnjrAl8EgJPZ0Mkrnw</link><description></description><content:encoded><![CDATA[【FDA】4月，4款创新药来袭！今年已有20款获批]]></content:encoded><pubDate>Fri, 07 May 2021 17:01:04 +0800</pubDate></item><item><title>扬子江厉害！90个新品紧盯超500亿市场，57个过评品种亮眼，11个拟集采品种霸屏</title><link>https://mp.weixin.qq.com/s/s33TqMb0L2-9KL_Ngop0cQ</link><description></description><content:encoded><![CDATA[扬子江厉害！90个新品紧盯超500亿市场，57个过评品种亮眼，11个拟集采品种霸屏]]></content:encoded><pubDate>Thu, 06 May 2021 16:16:27 +0800</pubDate></item><item><title>【重磅】齐鲁将拿下40亿大品种，10个新品已获批</title><link>https://mp.weixin.qq.com/s/AnM-G3hYltJyeaVosv2z1g</link><description></description><content:encoded><![CDATA[【重磅】齐鲁将拿下40亿大品种，10个新品已获批]]></content:encoded><pubDate>Thu, 06 May 2021 16:16:27 +0800</pubDate></item><item><title>【瞩目】石药发威！3大重磅新品同日获批</title><link>https://mp.weixin.qq.com/s/u8LSkgmIcYNUGRzZsRPXUw</link><description></description><content:encoded><![CDATA[【瞩目】石药发威！3大重磅新品同日获批]]></content:encoded><pubDate>Thu, 06 May 2021 16:16:27 +0800</pubDate></item><item><title>【关注】冲刺“抗肿瘤一哥”，这家企业3款产品接连过评</title><link>https://mp.weixin.qq.com/s/YiSrcU8SE5q9zD-QtGWrtw</link><description></description><content:encoded><![CDATA[【关注】冲刺“抗肿瘤一哥”，这家企业3款产品接连过评]]></content:encoded><pubDate>Thu, 06 May 2021 16:16:27 +0800</pubDate></item><item><title>68家药企销售费用曝光！这8家“烧了”40多亿，复星、科伦、海正……销售费用下降</title><link>https://mp.weixin.qq.com/s/nrmXM5e4bKSFCRxgpls3Jg</link><description></description><content:encoded><![CDATA[68家药企销售费用曝光！这8家“烧了”40多亿，复星、科伦、海正……销售费用下降]]></content:encoded><pubDate>Wed, 05 May 2021 07:49:53 +0800</pubDate></item><item><title>惊呆了！155家药企研发投入过亿，17家超10亿，9家翻倍，“研发王”砸了83亿</title><link>https://mp.weixin.qq.com/s/YuUv8cUSoxHISDESZh5IVw</link><description></description><content:encoded><![CDATA[惊呆了！155家药企研发投入过亿，17家超10亿，9家翻倍，“研发王”砸了83亿]]></content:encoded><pubDate>Tue, 04 May 2021 07:44:57 +0800</pubDate></item></channel></rss>